Home›Short-Acting Antacids

Short-Acting Antacids

Also known as: Wal-Act

Check Short-Acting Antacids Interactions →

9 interactions on record

Short-Acting Antacids has 9 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Albuterol Sulfate, Levalbuterol Tartrate, Avutometinib Potassium And Defactinib Hydrochloride. Patients taking Short-Acting Antacids should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 9
Contraindicated: 2
Moderate: 6
Minor: 1

Contraindicated (2)

Short-Acting Antacids + Albuterol Sulfate— Should not be used concomitantly with Albuterol Sulfate Inhalation Aerosol due to risk of potentiating effects.
Short-Acting Antacids + Levalbuterol Tartrate— Should not be used concomitantly with levalbuterol tartrate; may potentiate effects and cause deleterious cardiovascular…

Moderate (6)

Short-Acting Antacids + Avutometinib Potassium And Defactinib Hydrochloride— If use cannot be avoided, administer FAKZYNJA 2 hours before or 2 hours after the antacid to minimize exposure reduction…
Short-Acting Antacids + Cefuroxime Axetil— Reduce gastric acidity and may lower bioavailability of cefuroxime axetil. Administer at least 1 hour before or 2 hours …
Short-Acting Antacids + Fluoxetine Hydrochloride— Caution advised with concomitant administration; consider lower initial doses, conservative titration, and clinical moni…
Short-Acting Antacids + Olanzapine And Fuoxetine— Caution advised with concomitant CNS-active drugs; consider lower initial doses and conservative titration schedules.
Short-Acting Antacids + Olanzapine And Samidorphan L-Malate— Concomitant use may potentiate orthostatic hypotension observed with olanzapine. LYBALVI should be used with caution.
Short-Acting Antacids + Selpercatinib— Concomitant use decreases selpercatinib plasma concentrations, which may reduce anti-tumor activity. Avoid coadministrat…

Minor (1)

Short-Acting Antacids + Aclidinium Bromide— Concurrent administration showed no increases in adverse drug reactions in clinical studies.

Short-Acting Antacids + Albuterol Sulfate⛔Contraindicated

Should not be used concomitantly with Albuterol Sulfate Inhalation Aerosol due to risk of potentiating effects.

Short-Acting Antacids + Levalbuterol Tartrate⛔Contraindicated

Should not be used concomitantly with levalbuterol tartrate; may potentiate effects and cause deleterious cardiovascular effects.

Short-Acting Antacids + Avutometinib Potassium And Defactinib Hydrochloride🟡Moderate

If use cannot be avoided, administer FAKZYNJA 2 hours before or 2 hours after the antacid to minimize exposure reduction.

Short-Acting Antacids + Cefuroxime Axetil🟡Moderate

Reduce gastric acidity and may lower bioavailability of cefuroxime axetil. Administer at least 1 hour before or 2 hours after cefuroxime axetil.

Short-Acting Antacids + Fluoxetine Hydrochloride🟡Moderate

Caution advised with concomitant administration; consider lower initial doses, conservative titration, and clinical monitoring.

Short-Acting Antacids + Olanzapine And Fuoxetine🟡Moderate

Caution advised with concomitant CNS-active drugs; consider lower initial doses and conservative titration schedules.

Short-Acting Antacids + Olanzapine And Samidorphan L-Malate🟡Moderate

Concomitant use may potentiate orthostatic hypotension observed with olanzapine. LYBALVI should be used with caution.

Short-Acting Antacids + Selpercatinib🟡Moderate

Concomitant use decreases selpercatinib plasma concentrations, which may reduce anti-tumor activity. Avoid coadministration; if unavoidable, modify administration time.

Short-Acting Antacids + Aclidinium Bromide🟢Minor

Concurrent administration showed no increases in adverse drug reactions in clinical studies.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.